Merkel cell carcinoma-A rare primary neuroendocrine skin tumor: Case report and discussion
Author(s) -
Nidhi Gupta,
ShivpreetSingh Samra,
Vinod Nimbran,
Rakesh Kumar Gupta,
AshwinAnand Kallianpur,
Ujjawal Khurana
Publication year - 2014
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 1998-4138
pISSN - 0973-1482
DOI - 10.4103/0973-1482.136683
Subject(s) - merkel cell carcinoma , medicine , lymphadenectomy , chemotherapy , head and neck , merkel cell , radiation therapy , primary tumor , carcinoma , skin tumor , dermatology , wide local excision , lesion , disease , oncology , surgery , pathology , metastasis , cancer , carcinogenesis
Merkel cell carcinoma (MCC) is a rare but aggressive cutaneous primary small cell carcinoma with an unfavorable prognosis. It is a disease of the sun exposed skin of the elderly commonly involving the head, neck, and extremities. Though most cases present as localized disease, treatment should be definitive with wide excision of the primary lesion (2-3 cm margin) and prophylactic lymphadenectomy followed by irradiation to the primary site. Even when locoregional control is achieved, close surveillance is required due to high rates of local and systemic relapses. Chemotherapy is preserved for systemic disease, though the success of this treatment is limited and no chemotherapy protocol has been shown to improve survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom